The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
Capricor’s BLA for Deramiocel received Priority Review in March 2025
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The company has confirmed that the deceased are 39
Subscribe To Our Newsletter & Stay Updated